NO984365L - IgAl proteasefragment som bµrerpeptid - Google Patents

IgAl proteasefragment som bµrerpeptid

Info

Publication number
NO984365L
NO984365L NO984365A NO984365A NO984365L NO 984365 L NO984365 L NO 984365L NO 984365 A NO984365 A NO 984365A NO 984365 A NO984365 A NO 984365A NO 984365 L NO984365 L NO 984365L
Authority
NO
Norway
Prior art keywords
amino acid
carrier peptide
iga1 protease
protease fragment
peptide
Prior art date
Application number
NO984365A
Other languages
English (en)
Other versions
NO322265B1 (no
NO984365D0 (no
Inventor
Mark Achtman
Monique Moreau
Original Assignee
Max Planck Gesellschaft
Pasteur Merieux Serums Vacc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Max Planck Gesellschaft, Pasteur Merieux Serums Vacc filed Critical Max Planck Gesellschaft
Publication of NO984365D0 publication Critical patent/NO984365D0/no
Publication of NO984365L publication Critical patent/NO984365L/no
Publication of NO322265B1 publication Critical patent/NO322265B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
NO19984365A 1997-01-21 1998-09-18 Antigen baerer, fremgangsmate for dens fremstilling, dens anvendelse, konjugat samt vaksine. NO322265B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97100883 1997-01-21
PCT/EP1998/000294 WO1998031791A1 (en) 1997-01-21 1998-01-20 Iga1 protease fragment as carrier peptide

Publications (3)

Publication Number Publication Date
NO984365D0 NO984365D0 (no) 1998-09-18
NO984365L true NO984365L (no) 1998-11-19
NO322265B1 NO322265B1 (no) 2006-09-04

Family

ID=8226386

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19984365A NO322265B1 (no) 1997-01-21 1998-09-18 Antigen baerer, fremgangsmate for dens fremstilling, dens anvendelse, konjugat samt vaksine.

Country Status (14)

Country Link
US (1) US7235242B2 (no)
EP (1) EP0895537B1 (no)
JP (1) JP2000507274A (no)
KR (1) KR20000064740A (no)
AT (1) ATE283914T1 (no)
AU (1) AU6211698A (no)
CA (1) CA2249409C (no)
DE (1) DE69827880T2 (no)
DK (1) DK0895537T3 (no)
ES (1) ES2234095T3 (no)
NO (1) NO322265B1 (no)
NZ (1) NZ331968A (no)
PT (1) PT895537E (no)
WO (1) WO1998031791A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821859A1 (de) * 1998-05-15 1999-12-09 M Alexander Schmidt Darstellung immunogener (Kapsel-)Polysaccharid-Konjugate durch orientierte Kupplung synthetischer T-Zell-Epitope zur Erzeugung von Vakzinen gegen N.meningitidis
US10087221B2 (en) 2013-03-21 2018-10-02 Sanofi-Aventis Deutschland Gmbh Synthesis of hydantoin containing peptide products
AU2014234314B2 (en) 2013-03-21 2018-02-15 Sanofi-Aventis Deutschland Gmbh Synthesis of cyclic imide containing peptide products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3622221A1 (de) 1986-07-02 1988-01-14 Max Planck Gesellschaft Verfahren zur gentechnologischen gewinnung von proteinen unter verwendung gramnegativer wirtszellen
EP0326111A3 (en) * 1988-01-29 1989-12-27 New York Blood Center, Inc. Peptide derivatives rendered immunogenic when administered with alum as an adjuvant
DK130889A (da) * 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
GB8924438D0 (en) * 1989-10-31 1989-12-20 Hoffmann La Roche Vaccine composition

Also Published As

Publication number Publication date
US20040203108A1 (en) 2004-10-14
ATE283914T1 (de) 2004-12-15
JP2000507274A (ja) 2000-06-13
US7235242B2 (en) 2007-06-26
NO322265B1 (no) 2006-09-04
KR20000064740A (ko) 2000-11-06
AU6211698A (en) 1998-08-07
EP0895537B1 (en) 2004-12-01
DE69827880D1 (de) 2005-01-05
CA2249409A1 (en) 1998-07-23
NO984365D0 (no) 1998-09-18
WO1998031791A1 (en) 1998-07-23
PT895537E (pt) 2005-04-29
CA2249409C (en) 2010-10-26
ES2234095T3 (es) 2005-06-16
NZ331968A (en) 1999-05-28
DE69827880T2 (de) 2005-11-03
DK0895537T3 (da) 2005-03-29
EP0895537A1 (en) 1999-02-10

Similar Documents

Publication Publication Date Title
CY1109978T1 (el) Αντιγονικα πεπτιδια εξαγομενα απο τελομεραση
AR018603A1 (es) Un peptido, util para el tratamiento y/o profilaxis de la enfermedad de alzheimer y el sindrome de down, las composiciones farmaceuticas y vacunas que locontienen, el uso de dicho peptido para la preparacion de las composiciones farmaceuticas, una secuencia de aislado de adn, un plasmido o vector vi
NO20020348D0 (no) Peptid acceptor ligeringsmetoder
EP0591524A4 (no)
DE60021497D1 (de) Menschliche, für zyklische Nukleotide spezifische Phosphodiesterase
ATE368053T1 (de) Antimikrobielle peptide
ES2192620T3 (es) Polipeptido receptor de il-13.
CY1106978T1 (el) Ενζυμα φωσφοδιεστερασης
EP1548107A4 (en) CHROMOPROTEIN AND FLUOROPROTEINS
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
DE60237791D1 (de) Zytokinproteinfamilie
GB9801408D0 (en) Frozen food product
GB0020331D0 (en) Enzyme
DK0918865T3 (da) Immunologisk aktive proteiner af Borrelia burgdorferi, derfor kodende nukleinsyrer samt deres anvendelse i testkits og som vacciner
ES2185628T3 (es) Procedimiento para preparar proteinas modificadas.
NO984365L (no) IgAl proteasefragment som bµrerpeptid
GB9914045D0 (en) Novel compounds
AR033979A1 (es) Metodo para preparar un polipeptido il-18 fisiologicamente activo
DE602004028266D1 (de) Angiogene peptide und ihre verwendungen
HK1043149A1 (zh) 腫瘤反射抗原
NO20012232L (no) Enzymatisk amidering av peptider
PE20000759A1 (es) Gen de la citocroma oxidasa de hidroquinona del tipo bd
CO5060478A1 (es) Secuencia del gen relacionado con agiopoyetina scarface 3
PE20001068A1 (es) Produccion de analogos de tripsinogeno recombinante solubles
GB2357507A (en) Peptide fragments of cholera toxin B or enterotoxin B as vaccine adjuvants

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees